Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127952271 | 12795227 | 1 | I | 20160913 | 20160929 | 20160929 | EXP | BR-PFIZER INC-2016433469 | PFIZER | 57.00 | YR | F | Y | 67.00000 | KG | 20160929 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127952271 | 12795227 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, UNK | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | ||||||||
| 127952271 | 12795227 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, UNK | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127952271 | 12795227 | 1 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127952271 | 12795227 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127952271 | 12795227 | Drug ineffective | |
| 127952271 | 12795227 | Feeling abnormal | |
| 127952271 | 12795227 | Panic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |